Diagnostic limitations of pleural fluid analysis often led to reliance on indirect markers such as lymphocytosis or elevated adenosine deaminase (ADA) for suspected tuberculosis, or the presence of atypical/malignant cells for cancer, creating ambiguity in clinical decision-making [3]. The gene discussed is ADA; the disease is cancer.